; or (ii) that include industry-university research partnership programs. (C) Tracking In each year, the Director of the National Institutes of Health shall track the aggregate amount of grants, contracts, or other transactions awarded by the Director to entities in that year, disaggregated by innovation center. (D) Authorization of additional appropriations There are authorized to be appropriated to carry out this paragraph, in addition to amounts that would otherwise be appropriated in a year for the National Institutes of Health, amounts as follows: (i) For fiscal year 2021, $0. (ii) For fiscal year 2022, $140,000,000. (iii) For fiscal year 2023, $280,000,000. (iv) For fiscal year 2024, $420,000,000. (v) For fiscal year 2025, $560,000,000. (vi) For fiscal year 2026, $700,000,000. (vii) For fiscal year 2027, $840,000,000. (viii) For fiscal year 2028, $980,000,000. (ix) For fiscal year 2029, $1,120,000,000. (x) For fiscal year 2030, $1,260,000,000. (c) Tax incentives (1) New markets tax credit allocations Subsection (f) of section 45D of the Internal Revenue Code of 1986 is amended by adding at the end the following new paragraph: (4) Special allocation for innovation centers In the case of any calendar year beginning after 2021— (A) the limitation under paragraph (1) (including in calendar years for which the limitation under paragraph (1) is zero) shall be increased by $50,000,000 for each metropolitan statistical area which is designated as an innovation center under section 3(e) of the Innovation Centers Acceleration Act for such calendar year, and (B) the additional limitation under subparagraph (A) shall be divided equally among such innovation centers and allocated (as provided in paragraph (2)) among qualified community development entities in such innovation centers. . (2) Research credit (A) In general Section 41 of such Code is amended by adding at the end the following new subsection: (i) Special rules relating to innovation centers (1) In general In the case of— (A) any qualified research expenses